Lakewood-Amedex to Present at the 11th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 30, 2018 / Lakewood-Amedex, a leading developer of novel anti-infective pharmaceuticals, today announced that it will be presenting at the 11th annual LD Micro Main Event on Thursday, December 6 at 11:00 AM PST / 2:00 PM EST. Steve Parkinson, CEO of Lakewood-Amedex will be presenting and meeting with investors.

Presentation Details
Date: Thursday, December 6, 2018
Time: 11:00 AM PST
Location: Luxe Sunset Bel Air Hotel, Los Angeles

“Internally, our entire year leads up to the Main Event. It has become the ‘one thing’ everyone in the small and micro-cap world knows us for. Also, free mints,” stated Chris Lahiji, while enjoying a mint. “Even though LD has emerged as one of the largest and most influential organizations in the space, our focus has never deviated from showcasing some of the most interesting businesses in the world to our ever-growing community.”

The LD Micro Main Event will take place December 4th, 5th, and 6th, in Los Angeles at the Luxe Sunset Bel Air Hotel, will feature 250 companies, and will be attended by over 1,200 individuals.

Profiles powered by LD Micro — News Compliments of Accesswire

About Lakewood-Amedex, Inc.

Lakewood-Amedex is a clinical stage pharmaceutical company developing a broad portfolio of anti-infective products, including first-in-class antimicrobial compounds. The Company’s products and technology are covered by an extensive patent portfolio consisting of over 60 granted and/or issued patents and six pending patent applications covering many major pharmaceutical markets. The Company’s lead therapeutic candidate is a novel synthetic broad-spectrum antimicrobial proven to be effective in killing a wide range of Gram-positive, Gram-negative and antibiotic-resistant bacteria and has recently completed a Phase 1/2a clinical trial in patients with infected diabetic foot ulcers (iDFU).

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.

What started out as a newsletter highlighting unique companies has transformed into several influential events annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contacts:

Tiberend Strategic Advisors, Inc.
Jonathon Brzezinski, Ph.D. (Investors)
jbrzezinski@tiberend.com
(212) 375-2681

Tiberend Strategic Advisors, Inc.
David Schemelia (Media)
dschemelia@tiberend.com
(212) 375-2686

SOURCE: Lakewood-Amedex via LD Micro

ReleaseID: 529474